Oxford Asset Management’s American Renal Associates Holdings, Inc ARA Stock Holding History

Oxford Asset Management’s Portfolio ARA Stock Details ARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-44,680	Closed	-$463K	–	1647
2019 Q4	$463K	Sell	44,680 -30,745	-41%	-$263K	0.01%	1266
2019 Q3	$477K	Buy	75,425 +14,439	+24%	+$108K	0.01%	1281
2019 Q2	$454K	Sell	60,986 -195	-0.3%	-$1.29K	0.01%	1313
2019 Q1	$376K	Sell	61,181 -48,756	-44%	-$565K	0.01%	1345
2018 Q4	$1.27M	Sell	109,937 -43,754	-28%	-$746K	0.03%	734
2018 Q3	$3.28M	Buy	153,691 +100,126	+187%	+$1.89M	0.07%	394
2018 Q2	$857K	Sell	53,565 -36,223	-40%	-$569K	0.02%	1120
2018 Q1	$1.69M	Buy	89,788 +19,053	+27%	+$376K	0.04%	666
2017 Q4	$1.25M	Buy	70,735 +51,217	+262%	+$707K	0.03%	827
2017 Q3	$290K	Buy	+19,518	New	+$307K	0.01%	1348
2017 Q2	–	Sell	-14,067	Closed	-$237K	–	1780
2017 Q1	$237K	Buy	+14,067	New	+$281K	0.01%	1275

Other funds holding ARA

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WIC

Whitegate Investment Counselors Concord, New Hampshire $351M AUM 16.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Oxford Asset Management's ARA Position: Q1 2020 in Review

Oxford Asset Management sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2020, closing a stake of 44,680 shares — an estimated $463K sold.

Oxford Asset Management first reported a position in ARA in Q1 2017 and held it in 11 quarters. The position peaked at $3.28M in Q3 2018. 63 funds tracked by Wall St. Rank hold ARA as of Q1 2020.

Oxford Asset Management reported no remaining American Renal Associates Holdings, Inc position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 44,680 American Renal Associates Holdings, Inc shares in Q1 2020, an estimated $463K.
Oxford Asset Management first reported a position in American Renal Associates Holdings, Inc in Q1 2017 and held it in 11 quarters.
Oxford Asset Management's American Renal Associates Holdings, Inc position peaked at $3.28M in Q3 2018.
63 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.